137 related articles for article (PubMed ID: 35849260)
1. Effect of chronic lithium on mechanical sensitivity and trabecular bone loss induced by type-1 diabetes mellitus in mice.
Graniel-Amador MA; Torres-Rodríguez HF; Martínez-Mendoza RE; Vargas-Muñoz VM; Acosta-González RI; Castañeda-Corral G; Muñoz-Islas E; Jiménez-Andrade JM
Biometals; 2022 Oct; 35(5):1033-1042. PubMed ID: 35849260
[TBL] [Abstract][Full Text] [Related]
2. High fat diet attenuates hyperglycemia, body composition changes, and bone loss in male streptozotocin-induced type 1 diabetic mice.
Carvalho AL; DeMambro VE; Guntur AR; Le P; Nagano K; Baron R; de Paula FJA; Motyl KJ
J Cell Physiol; 2018 Feb; 233(2):1585-1600. PubMed ID: 28631813
[TBL] [Abstract][Full Text] [Related]
3. The effect of insulin therapy on biomechanical deterioration of bone in streptozotocin (STZ)-induced type 1 diabetes mellitus in rats.
Erdal N; Gürgül S; Demirel C; Yildiz A
Diabetes Res Clin Pract; 2012 Sep; 97(3):461-7. PubMed ID: 22483749
[TBL] [Abstract][Full Text] [Related]
4. TLR4 knockout ameliorates streptozotocin-induced osteoporosis in a mouse model of diabetes.
Cao Y; Han X; Wang Z; Liu Y; Wang Y; Zhang R; Ye J; Zou L; Dai W
Biochem Biophys Res Commun; 2021 Mar; 546():185-191. PubMed ID: 33601314
[TBL] [Abstract][Full Text] [Related]
5. Chronic administration of Cl-amidine, a pan-peptidylarginine deiminase inhibitor, does not reverse bone loss in two different murine models of osteoporosis.
Vargas-Muñoz VM; Martínez-Martínez A; Muñoz-Islas E; Ramírez-Rosas MB; Acosta-González RI; Jiménez-Andrade JM
Drug Dev Res; 2020 Feb; 81(1):93-101. PubMed ID: 31633211
[TBL] [Abstract][Full Text] [Related]
6. Streptozocin-induced type-1 diabetes mellitus results in decreased density of CGRP sensory and TH sympathetic nerve fibers that are positively correlated with bone loss at the mouse femoral neck.
Enríquez-Pérez IA; Galindo-Ordoñez KE; Pantoja-Ortíz CE; Martínez-Martínez A; Acosta-González RI; Muñoz-Islas E; Jiménez-Andrade JM
Neurosci Lett; 2017 Aug; 655():28-34. PubMed ID: 28652188
[TBL] [Abstract][Full Text] [Related]
7. Bone Morphogenetic Protein-6 Attenuates Type 1 Diabetes Mellitus-Associated Bone Loss.
Wang JF; Lee MS; Tsai TL; Leiferman EM; Trask DJ; Squire MW; Li WJ
Stem Cells Transl Med; 2019 Jun; 8(6):522-534. PubMed ID: 30784225
[TBL] [Abstract][Full Text] [Related]
8. Streptozotocin-induced diabetic models in mice and rats.
Wu KK; Huan Y
Curr Protoc Pharmacol; 2008 Mar; Chapter 5():Unit 5.47. PubMed ID: 22294227
[TBL] [Abstract][Full Text] [Related]
9. A pilot study: effect of irisin on trabecular bone in a streptozotocin-induced animal model of type 1 diabetic osteopathy utilizing a micro-CT.
Mohsin S; Brock F; Kaimala S; Greenwood C; Sulaiman M; Rogers K; Adeghate E
PeerJ; 2023; 11():e16278. PubMed ID: 37868046
[TBL] [Abstract][Full Text] [Related]
10. Withaferin-A attenuates multiple low doses of Streptozotocin (MLD-STZ) induced type 1 diabetes.
Tekula S; Khurana A; Anchi P; Godugu C
Biomed Pharmacother; 2018 Oct; 106():1428-1440. PubMed ID: 30119216
[TBL] [Abstract][Full Text] [Related]
11. Diabetic characteristics and alveolar bone loss in streptozotocin- and streptozotocin-nicotinamide-treated rats with periodontitis.
Kim JH; Lee DE; Choi SH; Cha JH; Bak EJ; Yoo YJ
J Periodontal Res; 2014 Dec; 49(6):792-800. PubMed ID: 24490978
[TBL] [Abstract][Full Text] [Related]
12. Protection against T1DM-Induced Bone Loss by Zinc Supplementation: Biomechanical, Histomorphometric, and Molecular Analyses in STZ-Induced Diabetic Rats.
Bortolin RH; da Graça Azevedo Abreu BJ; Abbott Galvão Ururahy M; Costa de Souza KS; Bezerra JF; Loureiro MB; da Silva FS; Marques DE; Batista AA; Oliveira G; Luchessi AD; Lima VM; Miranda CE; Lia Fook MV; Almeida Md; de Rezende LA; de Rezende AA
PLoS One; 2015; 10(5):e0125349. PubMed ID: 25933189
[TBL] [Abstract][Full Text] [Related]
13. Anabolic Effect of Insulin Therapy on the Bone: Osteoprotegerin and Osteocalcin Up-Regulation in Streptozotocin-Induced Diabetic Rats.
Bortolin RH; Freire Neto FP; Arcaro CA; Bezerra JF; da Silva FS; Ururahy MA; Souza KS; Lima VM; Luchessi AD; Lima FP; Lia Fook MV; da Silva BJ; Almeida MD; Abreu BJ; de Rezende LA; de Rezende AA
Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):227-234. PubMed ID: 27651300
[TBL] [Abstract][Full Text] [Related]
14. Ghrelin system is involved in improvements in glucose metabolism mediated by hyperbaric oxygen treatment in a streptozotocin‑induced type 1 diabetes mouse model.
Song L; Yuan J; Liu Y; Zhang D; Zhang C; Lin Q; Li M; Su K; Li Y; Gao G; Ma R; Dong J
Mol Med Rep; 2020 Nov; 22(5):3767-3776. PubMed ID: 32901885
[TBL] [Abstract][Full Text] [Related]
15. Role of osteogenic Dickkopf-1 in bone remodeling and bone healing in mice with type I diabetes mellitus.
Hildebrandt N; Colditz J; Dutra C; Goes P; Salbach-Hirsch J; Thiele S; Hofbauer LC; Rauner M
Sci Rep; 2021 Jan; 11(1):1920. PubMed ID: 33479403
[TBL] [Abstract][Full Text] [Related]
16. Different bone sites-specific response to diabetes rat models: Bone density, histology and microarchitecture.
Hua Y; Bi R; Zhang Y; Xu L; Guo J; Li Y
PLoS One; 2018; 13(10):e0205503. PubMed ID: 30346963
[TBL] [Abstract][Full Text] [Related]
17. Streptozotocin is equally diabetogenic whether administered to fed or fasted mice.
Chaudhry ZZ; Morris DL; Moss DR; Sims EK; Chiong Y; Kono T; Evans-Molina C
Lab Anim; 2013 Oct; 47(4):257-65. PubMed ID: 23760565
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of type 1 diabetes mellitus and subsequent osteoblastic β-catenin activation on trabecular and cortical bone in a mouse model.
Chen S; Liu D; He S; Yang L; Bao Q; Qin H; Liu H; Zhao Y; Zong Z
Exp Mol Med; 2018 Dec; 50(12):1-14. PubMed ID: 30518745
[TBL] [Abstract][Full Text] [Related]
19. Swimming training potentiates the recovery of femoral neck strength in young diabetic rats under insulin therapy.
Gomes GJ; Carlo RJD; Silva MFD; Cunha DNQD; Silva ED; Silva KAD; Carneiro-Junior MA; Prímola-Gomes TN; Natali AJ
Clinics (Sao Paulo); 2019; 74():e829. PubMed ID: 31038563
[TBL] [Abstract][Full Text] [Related]
20. Ganglioside therapy of type I diabetes: enhancement of hyperglycemia in the low dose streptozotocin model.
Zielasek J; Kolb H
Life Sci; 1992; 51(1):49-52. PubMed ID: 1535407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
